Analyst Ratings for Madrigal Pharmaceuticals (MDGL) [Buys]
MDGL Rating Summary
MDGL Price Target Summary
- Highest: $565.00 (Goldman Sachs)
- Lowest: $150.00 (BofA Securities)
- Average: $379.42
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$379.42 (+95.2%)
* Over Last 12-Mos
Rating Score: 7.9 / 10
Percentile Rank: 83%
Avg. $ Target:
$379.42 (+95.2%)
* Over Last 12-Mos
Rating Score: 7.9 / 10
Percentile Rank: 83%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/6/2024 | Citi » Updated 3/18/2024 |
David Lebowitz | New Coverage | Buy (N/A) |
389.00 (N/A) |
246.56 (194.38) |
-21.16% | Details |
| 10/7/2021 | Jefferies » Updated 3/15/2024 |
Akash Tewari | New Coverage | Buy (N/A) |
400.00 (321.00) |
78.62 (194.38) |
147.24% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
